ATALANTE Trademark

Trademark Overview

On Monday, July 4, 2016, a trademark application was filed for ATALANTE with the United States Patent and Trademark Office. The USPTO has given the ATALANTE trademark a serial number of 87092387. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 12, 2024. This trademark is owned by OSE Immunotherapeutics. The ATALANTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others
atalante

General Information

Serial Number87092387
Word MarkATALANTE
Filing DateMonday, July 4, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 12, 2024
Registration Number5231070
Registration DateTuesday, June 27, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2017

Trademark Statements

Goods and ServicesConducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOSE Immunotherapeutics
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address44000 NANTES
FR
Party NameOSE Immunotherapeutics
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address44000 NANTES
FR
Party NameOSE Immunotherapeutics
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address44000 NANTES
FR

Trademark Events

Event DateEvent Description
Friday, January 12, 2024CANCELLED SEC. 8 (6-YR)
Monday, June 27, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 27, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, April 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 4, 2017ASSIGNED TO LIE
Friday, February 24, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 15, 2016NON-FINAL ACTION E-MAILED
Thursday, December 15, 2016NON-FINAL ACTION WRITTEN
Monday, November 21, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 21, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 8, 2016ASSIGNED TO LIE
Thursday, October 27, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, October 23, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, October 23, 2016LETTER OF SUSPENSION E-MAILED
Sunday, October 23, 2016SUSPENSION LETTER WRITTEN
Thursday, October 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 13, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 13, 2016NON-FINAL ACTION E-MAILED
Thursday, October 13, 2016NON-FINAL ACTION WRITTEN
Thursday, October 13, 2016ASSIGNED TO EXAMINER
Thursday, July 7, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 7, 2016NEW APPLICATION ENTERED

Related Keywords

atalante others trials clinical conducting